Systemic sclerosis: from pathophysiology to novel therapeutic approaches
D Benfaremo, S Svegliati, C Paolini, S Agarbati… - Biomedicines, 2022 - mdpi.com
Systemic sclerosis (SSc) is a systemic, immune-mediated chronic disorder characterized by
small vessel alterations and progressive fibrosis of the skin and internal organs. The …
small vessel alterations and progressive fibrosis of the skin and internal organs. The …
Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast
A Sierra-Sepúlveda… - BioMed research …, 2019 - Wiley Online Library
Systemic sclerosis (SSc) is a complex rheumatologic autoimmune disease in which
inflammation, fibrosis, and vasculopathy share several pathogenic pathways that lead to …
inflammation, fibrosis, and vasculopathy share several pathogenic pathways that lead to …
Pathophysiology of systemic sclerosis: current understanding and new insights
M Cutolo, S Soldano, V Smith - Expert review of clinical …, 2019 - Taylor & Francis
ABSTRACT Introduction: Systemic sclerosis (SSc) is a complex autoimmune connective
tissue disease characterized by chronic and progressive tissue and organ fibrosis with …
tissue disease characterized by chronic and progressive tissue and organ fibrosis with …
Vascular remodelling and mesenchymal transition in systemic sclerosis
PA Nicolosi, E Tombetti, N Maugeri… - Stem Cells …, 2016 - Wiley Online Library
Fibrosis of the skin and of internal organs, autoimmunity, and vascular inflammation are
hallmarks of Systemic Sclerosis (SSc). The injury and activation of endothelial cells, with …
hallmarks of Systemic Sclerosis (SSc). The injury and activation of endothelial cells, with …
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
J Varga, M Trojanowska… - Journal of Scleroderma …, 2017 - journals.sagepub.com
Systemic sclerosis (SSc) is a complex disease characterized by early microvascular
abnormalities, immune dysregulation and chronic inflammation, and subsequent fibrosis of …
abnormalities, immune dysregulation and chronic inflammation, and subsequent fibrosis of …
Systemic sclerosis: current views of its pathogenesis
CT Derk, SA Jimenez - Autoimmunity reviews, 2003 - Elsevier
Systemic sclerosis (SSc) is an autoimmune disorder of unknown etiology characterized by
severe and often progressive cutaneous and visceral fibrosis, pronounced alterations in the …
severe and often progressive cutaneous and visceral fibrosis, pronounced alterations in the …
Emerging targets of disease-modifying therapy for systemic sclerosis
ER Volkmann, J Varga - Nature Reviews Rheumatology, 2019 - nature.com
Systemic sclerosis (SSc) has the highest cause-specific mortality of all the connective tissue
diseases, and the aetiology of this complex and heterogeneous condition remains an …
diseases, and the aetiology of this complex and heterogeneous condition remains an …
Recent advances on pathogenesis and therapies in systemic sclerosis
N Yazawa, M Fujimoto, K Tamaki - Clinical reviews in allergy & …, 2007 - Springer
Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by extensive
fibrotic changes in various organs, including skin and lung. Although the etiology of SSc …
fibrotic changes in various organs, including skin and lung. Although the etiology of SSc …
Current perspectives on the immunopathogenesis of systemic sclerosis
P Fuschiotti - ImmunoTargets and therapy, 2016 - Taylor & Francis
Systemic sclerosis (SSc or scleroderma) is a progressive and highly debilitating
autoimmune disorder characterized by inflammation, vasculopathy, and extensive fibrosis …
autoimmune disorder characterized by inflammation, vasculopathy, and extensive fibrosis …
Current frontiers in systemic sclerosis pathogenesis
M Ciechomska, J van Laar… - Experimental …, 2015 - Wiley Online Library
Systemic sclerosis is an autoimmune disease characterised by vascular dysfunction,
impaired angiogenesis, inflammation and fibrosis. There is no currently accepted disease …
impaired angiogenesis, inflammation and fibrosis. There is no currently accepted disease …